 PHILADELPHIA, Sept. 17, 2021 GLOBE NEWSWIRE -- Century Therapeutics NASDAQ: IPSC, an innovative biotechnology company developing induced pluripotent stem cell iPSC-derived cell therapies in immuno-oncology, today announced that it will be added to the small-cap Russell 2000 Index as a part of the 3Q21 Russell Indexes IPO additions, effective at US market open on September 20, 2021, according to the preliminary list of IPO additions to the Russell indexes. 